26.48
22-November-24 16:44:58
15 minutes delayed
Stocks
-5.70
-17.71%
Today's range
26.02 - 31.40
ISIN
N/A
Source
NASDAQ
Cassava Sciences’ Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study
02 Feb 2021 08:30:00 By Nasdaq GlobeNewswire
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer
04 Jan 2021 08:30:00 By Nasdaq GlobeNewswire